英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
zigrino查看　zigrino　在百度字典中的解释百度英翻中〔查看〕
zigrino查看　zigrino　在Google字典中的解释Google英翻中〔查看〕
zigrino查看　zigrino　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Aranesp® (darbepoetin alfa)
    Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis READ MORE
  • Aranesp® (darbepoetin alfa) | For Anemia Due to CKD
    ARANESP ® is a well-studied treatment given to more than 1 3 million people* with anemia due to CKD ARANESP ® is a prescription medicine used to treat anemia caused by CKD in patients on dialysis and not on dialysis It acts like a hormone called erythropoietin (ee-rith-row-PO-eh-tin)
  • Aranesp® (darbepoetin alfa) | Managing Anemia Due to CKD
    ARANESP ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting ARANESP ® READ MORE
  • Aranesp® (darbepoetin alfa) | Resources
    ARANESP ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting ARANESP ® READ MORE
  • Aranesp® (darbepoetin alfa) | Dosing Considerations
    Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting Aranesp ® Aranesp ® has not been proven to improve quality of life, fatigue, or well-being
  • Dosing Guidelines - Aranesp
    Aranesp® is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy
  • Aranesp® (darbepoetin alfa) | Red Blood Cell Response
    Aranesp ® (darbepoetin alfa) is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional
  • Aranesp® (darbepoetin alfa) | Aranesp Support
    Aranesp ® (darbepoetin alfa) is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional
  • Behind Aranesp are multiple dosing options
    A guide to dosing, administration, and conversion with Aranesp® in the management of anemia due to CKD in patients on dialysis 1 INDICATION Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis LIMITATIONS OF USE
  • Aranesp® (darbepoetin alfa) | Efficacy and Safety
    Aranesp ® (darbepoetin alfa) is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional





中文字典-英文字典  2005-2009